To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
7 Current news of ChemDiv
rss
Successful Milestone in Lead Discovery Collaboration with Nerviano Medical Sciences
03-03-2009
ChemDiv, Inc. announced that it has earned the successful milestone in its Lead Discovery collaboration with Nerviano Medical Sciences (NMS). In October 2007, ChemDiv and NMS expanded their partnership to discover and develop potential anticancer agents. Under the terms of the collaboration, ...
ChemDiv and Avineuro Extend Collaboration on Alzheimer's Disease and Schizophrenia
26-11-2008
ChemDiv Inc. and Avineuro Pharmaceuticals Inc. have extended the term of their research and development collaboration including formulation, safety and early clinical development studies in areas of neurodegenerative and psychiatric disorders. R&D services will be provided by Chemical ...
Oncalis AG Licenses PI3K Inhibitors From ChemDiv Inc.
08-10-2008
Oncalis AG (Oncalis), a privately-owned Swiss biotechnology company, and ChemDiv Inc. (ChemDiv), a privately-owned,California-based discovery services company announced that they entered into an exclusive agreement for a license to Oncalis a family of PI3K inhibitors. ONC-201, the first ...
Syndexa Pharmaceuticals and ChemDiv announce discovery collaboration
30-04-2008
ChemDiv, Inc. and Syndexa Pharmaceuticals Corporation have announced the signing of a collaborative discovery research agreement. Under the terms of the agreement, ChemDiv will discover small molecule ligands for biotargets nominated by Syndexa. Financial terms of the collaboration were not ...
ChemDiv to Supply Italien Nerviano Medical Sciences with Discovery Chemical Libraries
04-07-2006
ChemDiv, Inc. and Nerviano Medical Sciences (NervianoMS), Milano, Italy, announced an extension of their collaboration to an additional 2 year program. NervianoMS will use services of ChemDiv for building and enriching its portfolio of proprietary discovery chemical libraries. Such compound ...
ChemDiv and Berlex Announce Lead Compound Discovery Collaboration
14-03-2006
ChemDiv, Inc. announced that it has entered into a discovery research collaboration with Berlex Inc., a U.S. affiliate of Schering AG, Germany. The partners will work on the discovery of potential new lead compounds against several selected GPCR targets. Under the terms of the collaboration, ...
ChemDiv, Inc. and ProQinase GmbH to Partner in Lead Discovery and Preclinical Development in Oncology
08-11-2005
ChemDiv, Inc. and ProQinase GmbH Germany, announced that they have signed an agreement to establish a partnership in the discovery and preclinical development of new kinase inhibitors. Under the agreement ChemDiv will support design and synthesis of target-focused small molecule libraries, ...
Page 1 From 1
Netmeeting
